Paclitaxel, carboplatin and gemcitabine (PCG) as neoadjuvant therapy in patients with locally advanced transitional cell carcinoma (TCC) of the bladder.

被引：0
|
作者：
Smith, DC
Bhandari, M
Hussain, M
Montie, JE
Wood, DP
Lee, CT
Petrylak, DP
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Columbia Presbyterian Med Ctr, New York, NY USA
[3] Wayne State Univ, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4541
引用
收藏
页码：392S / 392S
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant paclitaxel (P), carboplatin (Ca) and gemcitabine (G) in patients with locally advanced transitional cell carcinoma (TCC) of the bladder: A final report.
    Smith, D. C.
    Mackler, N. J.
    Hussain, M. H.
    Dunn, R.
    Montie, J. E.
    Wood, D.
    Lee, C. T.
    Petrylak, D.
    Quinn, D.
    Vaishampayan, U.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 226S - 226S
  • [2] Is paclitaxel, cisplatin, and gemcitabine (PCG) feasible as neoadjuvant therapy for locally advanced bladder cancer (LABC)?
    Exman, Pedro
    Correa, Tatiana Strays
    Rocha, Claudio Lima
    Barbosa, Caroline Chaul
    Dzik, Carlos
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Neoadjuvant chemotherapy with gemcitabine and carboplatin followed by concurrent chemoradiotherapy in locally advanced carcinoma of urinary bladder.
    Ansari, TN
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 435S - 435S
  • [4] Phase II Trial of Paclitaxel, Carboplatin and Gemcitabine in Patients With Locally Advanced Carcinoma of the Bladder
    Smith, David C.
    Mackler, Niklas J.
    Dunn, Rodney L.
    Hussain, Maha
    Wood, David
    Lee, Cheryl T.
    Sanda, Martin
    Vaishampayan, Ulka
    Petrylak, Daniel P.
    Quinn, David I.
    Beekman, Kathleen
    Montie, James E.
    [J]. JOURNAL OF UROLOGY, 2008, 180 (06): : 2384 - 2388
  • [5] A Phase II Trial of Neoadjuvant nab-paclitaxel, Carboplatin, and Gemcitabine (ACaG) in Patients With Locally Advanced Carcinoma of the Bladder
    Grivas, Petros D.
    Hussain, Maha
    Hafez, Khaled
    Daignault-Newton, Stephanie
    Wood, David
    Lee, Cheryl T.
    Weizer, Alon
    Montie, James E.
    Hollenbeck, Brent
    Montgomery, Jeffrey S.
    Alva, Ajjai
    Smith, David C.
    [J]. UROLOGY, 2013, 82 (01) : 111 - 117
  • [6] Phase II Trial of Paclitaxel, Carboplatin and Gemcitabine in Patients With Locally Advanced Carcinoma of the Bladder COMMENT
    Tagawa, Scott T.
    [J]. JOURNAL OF UROLOGY, 2008, 180 (06): : 2388 - 2388
  • [7] Neoadjuvant Gemcitabine Plus Carboplatin for Locally Advanced Bladder Cancer
    Iwasaki, Kazuhiro
    Obara, Wataru
    Kato, Yoichiro
    Takata, Ryo
    Tanji, Susumu
    Fujioka, Tomoaki
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (02) : 193 - 199
  • [8] Intravesical gemcitabine (G) single agent as adjuvant chemotherapy in superficial transitional cell carcinoma (TCC) of bladder.
    Bouzid, K
    Ferhat, R
    Bounedjar, A
    Mahfouf, H
    Smaili, F
    Adjali, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 407S - 407S
  • [9] CARBOPLATIN AND GEMCITABINE IN ELDERLY AND/OR FRAIL PATIENTS (PTS) WITH ADVANCED TRANSITIONAL CELL CARCINOMA (TCC): A PHASE II STUDY
    Baitar, A.
    De Vos, M.
    Vandebroek, A.
    Schrijvers, D.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 281 - 281
  • [10] Phase II study of Taxol (paclitaxel) and Carboplatin in patients with advanced transitional-cell carcinoma of the urothelium (TCC)
    Mottet, N
    Prapotnich, D
    Beuzeboc, P
    Di Palma, M
    Bui, N
    Eymard, JC
    Mercat, A
    Garet, F
    Droz, JP
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 59 - 59
12345